Department of Ophthalmology, Democritus University of Thrace, Alexandroupolis, Greece.
BMC Ophthalmol. 2013 Nov 8;13:69. doi: 10.1186/1471-2415-13-69.
To quantify the levels of tissue inhibitor of metalloproteinase 4 (TIMP4) and its ratios with free metalloproteinases (MMP) in the aqueous humor of patients with primary open angle glaucoma (POAG), pseudoexfoliation syndrome (PXS) and pseudoexfoliative glaucoma (PXG) and to evaluate a possible imbalance between MMPs and TIMPs in these samples.
Free MMP2, MMP3, MMP9, TIMP1, TIMP2, TIMP4 concentrations and active levels of MMP2 and MMP3 were determined with immunoassay ELISA and activity assay kits in 168 aqueous samples.
TIMP4 was elevated in glaucoma patients(POAG: 0.95 ± 0.49 PXG: 1.28 ± 1.38 pg/ml. p < 0.001). POAG, PXS and PXG samples demonstrated higher MMP2, TIMP1 and TIMP2 concentrations (p < 0.001). Samples from the PXS and PXG groups had a lower total/active MMP2 ratio (p < 0.004 and p < 0.008 respectively). Stoichiometric analysis showed an overbalance of TIMPsover MMPs in both POAG & PXG groups,especially of TIMP4.
TIMP4 elevation is a novel finding in glaucomatous eyes. A disregulation of extracellular matrix homeostasis is suggested in POAG, PXS and PXG.
定量原发性开角型青光眼(POAG)、剥脱综合征(PXS)和剥脱性青光眼(PXG)患者房水中金属蛋白酶抑制剂 4(TIMP4)及其与游离金属蛋白酶(MMP)的比值,并评估这些样本中 MMP 和 TIMP 之间可能存在的失衡。
采用免疫酶联吸附试验(ELISA)和活性检测试剂盒检测 168 例房水样本中游离 MMP2、MMP3、MMP9、TIMP1、TIMP2、TIMP4 浓度和 MMP2、MMP3 的活性水平。
青光眼患者 TIMP4 升高(POAG:0.95±0.49,PXG:1.28±1.38 pg/ml,p<0.001)。POAG、PXS 和 PXG 样本中 MMP2、TIMP1 和 TIMP2 浓度较高(p<0.001)。PXS 和 PXG 组的总/活性 MMP2 比值较低(p<0.004 和 p<0.008)。化学计量分析显示,POAG 和 PXG 组中 TIMP 对 MMP 的失衡更为明显,尤其是 TIMP4。
TIMP4 升高是青光眼眼中的一个新发现。提示 POAG、PXS 和 PXG 存在细胞外基质稳态失调。